Aristo Bio-Tech And Lifescience Limited — Others, 04-07-2025: Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter

Aristo Bio-tech and Lifescience Limited has clarified that it qualifies for an exemption from filing quarterly, half-yearly, and yearly Corporate Governance Reports under SEBI regulations, as its equity shares are listed on the NSE SME Emerge Platform. This means the company is not required to submit these specific governance disclosures, reflecting its current listing status. This update affects compliance procedures but does not impact the company’s core operations or financials.